Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

After-hours movers: Zscaler falls post earnings, Smartsheet gains

Published 2022-12-01, 05:52 p/m
Updated 2022-12-01, 05:52 p/m
© Reuters.

After-Hours Stock Movers:

Samsara Inc (NYSE:IOT23% HIGHER; reported Q3 EPS of ($0.02), $0.04 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $169.8 million versus the consensus estimate of $155.33M. Samsara Inc sees Q4 2023 EPS of ($0.05)-($0.06), versus the consensus of ($0.06). Samsara Inc sees Q4 2023 revenue of $170-172M, versus the consensus of $161M.

Asana Inc (NYSE:ASAN12% LOWER; reported Q3 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $141.4M versus the consensus estimate of $139.01M. Asana, Inc. sees Q4 2023 EPS of ($0.28)-($0.27), versus the consensus of ($0.29). Asana, Inc. sees Q4 2023 revenue of $144-146M, versus the consensus of $151.06M. Asana, Inc. sees FY2023 EPS of ($1.15)-($1.14), versus the consensus of ($1.25). Asana, Inc. sees FY2023 revenue of $541-543M, versus the consensus of $545.89M.

Zscaler (NASDAQ:ZS) 10% LOWER; reported Q1 EPS of $0.29, $0.03 better than the analyst estimate of $0.26. Revenue for the quarter came in at $355.5M versus the consensus estimate of $340.68M. Zscaler sees Q2 2023 EPS of $0.29-$0.30, versus the consensus of $0.26. Zscaler sees Q2 2023 revenue of $364-366M, versus the consensus of $359M. Zscaler sees FY2023 EPS of $1.23-$1.25, versus the consensus of $1.18. Zscaler sees FY2023 revenue of $1.525-1.53 billion, versus the consensus of $1.51B.

Smartsheet (NYSE:SMAR) 9% HIGHER; reported Q3 EPS of ($0.01), $0.14 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $219.6M versus the consensus estimate of $193.59M. Smartsheet sees Q4 2023 EPS of ($0.02)-$0.00, versus the consensus of ($0.09). Smartsheet sees Q4 2023 revenue of $205-207M, versus the consensus of $204M.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Uipath Inc (NYSE:PATH8% HIGHER; reported Q3 EPS of $0.05, $0.09 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $262.7M versus the consensus estimate of $245.39M. UiPath Inc. sees Q4 2023 revenue of $277-279M, versus the consensus of $275M.

Marvell Technology (NASDAQ:MRVL) 7% LOWER; reported Q3 EPS of $0.57, $0.02 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $1.54B versus the consensus estimate of $1.56B. Marvell Technology sees Q4 2023 EPS of $0.41-$0.51, versus the consensus of $0.62. Marvell Technology sees Q4 2023 revenue of $1.4B, versus the consensus of $1.61B.

Paycor HCM Inc (NASDAQ:PYCR) 5% LOWER; announced the commencement of an underwritten public offering of 5,000,000 shares of common stock on behalf of investment funds advised by Apax Partners LLP

PagerDuty, Inc. (NYSE:PD) 4% HIGHER; reported Q3 EPS of $0.04, $0.07 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $94.2M versus the consensus estimate of $92.95M. PagerDuty, Inc. sees Q4 2023 EPS of $0.02-$0.03, versus the consensus of $0.00. PagerDuty, Inc. sees Q4 2023 revenue of $98-100M, versus the consensus of $99M. PagerDuty, Inc. sees FY2023 EPS of ($0.01)-$0.00, versus the consensus of ($0.11). PagerDuty, Inc. sees FY2023 revenue of $368-370M, versus the consensus of $367.82M.

Veeva Systems (NYSE:VEEV) 2% LOWER; reported Q3 EPS of $1.13, $0.06 better than the analyst estimate of $1.07. Revenue for the quarter came in at $552.4M versus the consensus estimate of $545.98M. Veeva Systems sees Q4 2023 EPS of $1.05, versus the consensus of $1.07. Veeva Systems sees Q4 2023 revenue of $551-553M, versus the consensus of $557M.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Ulta Beauty (NASDAQ:ULTA) 1% HIGHER; reported Q3 EPS of $5.34, $1.25 better than the analyst estimate of $4.09. Revenue for the quarter came in at $2.3B versus the consensus estimate of $2.2B. Ulta Beauty sees FY2023 EPS of $22.60-$22.90, versus the consensus of $21.40. Ulta Beauty sees FY2023 revenue of $9.95-10B, versus the consensus of $9.77B.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.